Viewed collectively, our findings show the anti-inflammatory effects of CR in the CT-2A astrocytoma are associated with inhibition of the NF-κB pathway and the linked pro-inflammatory molecules. This evidence concerns the gene NFKB1 and astrocytoma (excluding glioblastoma).